Roivant Sciences Ltd.
$28.32
$0.04(-0.14%)
Roivant Sciences Ltd.
ROIV
$28.32
$0.04(-0.14%)
Roivant Sciences Ltd.
ROIV
NASDAQ
$28.32
$0.04(-0.14%)
Chart
Upcoming Earnings
Next report date
May 28, 2026
Report period
Q2 2026
EPS Estimate
$-0.26
Revenue Estimate
$3.41M
Key stats
52-Week Range$28.32
$10.58
$30.33
Market capitalization
$20.27BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-23.97Basic EPS (TTM)
$-1.17Net income (TTM)
$-809.24MRevenue (TTM)
$13.31MAvg. volume
6.10MBeta (1Y)
1.14Employees
908Market capitalization
$20.27BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-23.97Basic EPS (TTM)
$-1.17Net income (TTM)
$-809.24MRevenue (TTM)
$13.31MAvg. volume
6.10MBeta (1Y)
1.14Employees
908Screener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Roivant Sciences Ltd.
Sector
Healthcare
Industry
Biotechnology
CEO
Matthew Gline
Website
roivant.comHeadquarters
11-12 St. James's Square, London, SW1Y 4LB
IPO Date
2020-12-08
Identifiers
ISIN
BMG762791017Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company...
Related Stocks
$147.21
1D:
-0.5%
1Y:
269.9%
US76155X1000Healthcare
Mkt Cap
$31.30B
P/E Ratio TTM
-23.4
Revenue TTM
$0.00
Beta
1.01
Earnings TTM
$-1.13B
Dividend Yield TTM
0.00%
$50.44
1D:
0.5%
1Y:
52.8%
GB00BMVP7Y09Healthcare
Mkt Cap
$21.61B
P/E Ratio TTM
27.7
Revenue TTM
$2.38B
Beta
0.39
Earnings TTM
$770.95M
Dividend Yield TTM
1.81%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate